Allied Market Research

2025

Oncology Blood Testing Market

Oncology Blood Testing Market, by Gender Segment (Male, Female), by Patient Type Segment (Adults, Children), by Testing Type Segment (Complete Blood Count, Tumor Marker Tests, Molecular Oncology Tests, Other Blood Tests) and, by End-Use Segment (Hospitals, Diagnostic Centers, Pathology Laboratories): Opportunity Analysis and Industry Forecast, 2023-2032

LS : Other

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

The Oncology blood testing market report presents the current market analysis along with a seven-year market forecast. The report offers an extensive study of global Oncology blood testing market with detailed analysis of the significant factors affecting the market. The factors studied in the report include market dynamics, key segments, major geographies, leading players, and competitive scenario.

Report Includes:

  • 80+ data tables and self-explanatory graphs

  • An overview of the global market for Oncology blood testing market

  • Discussion of drivers, opportunities, and restraints

The report offers size and forecast by analyzing the global Oncology blood testing market with diverse segments classified on the basis of by gender segment, by patient type segment, by testing type segment, by end-use segment. Furthermore, it includes the geographical market analysis of these segments. Each segment is researched at global, regional, as well as country levels to gain a comprehensive understanding of the global Oncology blood testing market.

The competitive scenario of the global Oncology blood testing market is discussed in the report, providing detailed analysis on competitive landscape. The key players operating in the global Oncology blood testing market are studied to acknowledge their share, position, and competitive strength in the market. Analysis of these major players is included in the report to assist in providing a detailed understanding of these players in the market. Furthermore, the company profile section provides different data points, including brief company overview, key executives of the company, major growth strategies adopted by the company, recent financials, new initiatives or strategies adopted by company to sustain and enhance their position and share in the global Oncology blood testing market, and with other competitors.

Key players analysed in this report are Abbott Laboratories, BD, Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Inc., Sysmex Corporation, Agilent Technologies, Inc., Ortho Clinical Diagnostics, Inc.

Key Questions Addressed By The Report:

  • What are the major applications of the Oncology blood testing market? How lucrative is the opportunity for their growth in the developing economies in the next nine years?

  • Which are the major companies in the Oncology blood testing market? What are their key strategies to reinforce their market position?

  • What are the leading countries in the Oncology blood testing market? What would be the share of North America and Asia-Pacific in this market in the next nine years?

  • Where will all these developments in the Oncology blood testing market take the industry in the mid to long term?

Research Methodology:

AMR offers its clients with a detailed study and research based on a broad variety of factual inputs, which mainly include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play a vital role in designing analytic tools and models, tailored as per the requirement of an industry segment.

For this research report, over 5,500 product/service type literatures, annual reports, industry releases, and other such documents of key industry participants have been studied for better market research. In addition, 20 hours of interviews have been conducted, with a wide range of professionals in the market, including upstream and downstream participants. Primary research is comprehensibly supported by extensive secondary research. Further, authentic industry journals, trade associations’ releases, and government websites have also been analyzed to obtain high-value industry insights.

Key Stakeholders

  • Players operating in the market

  • Suppliers

  • Governments Bodies

  • Distributors

  • C-level Executives

  • Venture Capitalists

  • Universities

Oncology Blood Testing Market Report Highlights

Aspects Details
icon_5
By Gender Segment
  • Male
  • Female
icon_6
By Patient Type Segment
  • Adults
  • Children
icon_7
By Testing Type Segment
  • Complete Blood Count
  • Tumor Marker Tests
  • Molecular Oncology Tests
  • Other Blood Tests
icon_8
By End-Use Segment
  • Hospitals
  • Diagnostic Centers
  • Pathology Laboratories
icon_9
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Russia, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
icon_10
Key Market Players

Danaher Corporation, Sysmex Corporation, Thermo Fisher Scientific Inc., Agilent Technologies, F. Hoffmann-La Roche Ltd, Beckman Coulter, Bio-Rad Laboratories, Abbott Laboratories, Ortho Clinical Diagnostics, BD

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Oncology Blood Testing Market

Opportunity Analysis and Industry Forecast, 2023-2032